COMMON STOCK PURCHASE WARRANT THERAPEUTICSMD, INC.Securities Agreement • February 6th, 2013 • TherapeuticsMD, Inc. • Pharmaceutical preparations • Florida
Contract Type FiledFebruary 6th, 2013 Company Industry JurisdictionThis is to certify that, for the payment of $100 and other good and valuable consideration received, PLATO & ASSOCIATES, LLC (the “Holder”), or its registered assigns, is entitled, at any time from the Issuance Date (as hereinafter defined) to the Expiration Date (as hereinafter defined), to purchase from THERAPEUTICSMD, INC., a Nevada corporation (the “Company”), One Million Two Hundred Fifty Thousand Shares (1,250,000) shares of the Company's Common Stock (as hereinafter defined and subject to adjustment as provided herein), in whole or in part, including fractional parts, at a purchase price per share equal to $3.20 subject to any adjustments made to such amount pursuant to Section 4 hereto) on the terms and conditions and pursuant to the provisions hereinafter set forth.
MULTIPLE ADVANCE REVOLVING CREDIT NOTEMultiple Advance Revolving Credit Note • February 6th, 2013 • TherapeuticsMD, Inc. • Pharmaceutical preparations • Florida
Contract Type FiledFebruary 6th, 2013 Company Industry JurisdictionFOR VALUE RECEIVED, TherapeuticsMD, Inc., a Nevada corporation ("Borrower"), hereby promises to pay to the order of Plato & Associates, LLC, a Missouri limited liability company ("Lender"), at the office of Lender located at 13650 Fiddlesticks Blvd., Suite 202, Ft. Myers, FL 33912, the principal amount of $10,000,000.00, or such lesser principal amount as from time to time shall be outstanding hereunder, as reflected in the books and records of Lender, together with interest on the principal balance from time to time outstanding hereunder, from (and including) the date of disbursement until (but not including) the date of payment, at a per annum rate equal to the Stated Interest Rate specified below or, to the extent applicable, the Default Interest Rate specified below, in accordance with the following terms and conditions: